Fiévet C - Search Results

1

3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase.

Schoonjans K, Peinado-Onsurbe J, Fruchart JC, Tailleux A, Fiévet C, Auwerx J. Schoonjans K, et al. Among authors: fievet c. FEBS Lett. 1999 Jun 11;452(3):160-4. doi: 10.1016/s0014-5793(99)00632-8. FEBS Lett. 1999. PMID: 10386582 Free article.

2

Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates.

Lefebvre AM, Peinado-Onsurbe J, Leitersdorf I, Briggs MR, Paterniti JR, Fruchart JC, Fievet C, Auwerx J, Staels B. Lefebvre AM, et al. Among authors: fievet c. Arterioscler Thromb Vasc Biol. 1997 Sep;17(9):1756-64. doi: 10.1161/01.atv.17.9.1756. Arterioscler Thromb Vasc Biol. 1997. PMID: 9327774

3

Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice.

Tailleux A, Bouly M, Luc G, Castro G, Caillaud JM, Hennuyer N, Poulain P, Fruchart JC, Duverger N, Fiévet C. Tailleux A, et al. Among authors: fievet c. Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):2453-8. doi: 10.1161/01.atv.20.11.2453. Arterioscler Thromb Vasc Biol. 2000. PMID: 11073852

4

Apolipoprotein A-I-containing particles and reverse cholesterol transport in IDDM.

Fievet C, Theret N, Shojaee N, Duchateau P, Castro G, Ailhaud G, Drouin P, Fruchart JC. Fievet C, et al. Diabetes. 1992 Oct;41 Suppl 2:81-5. doi: 10.2337/diab.41.2.s81. Diabetes. 1992. PMID: 1526342

5

HDL heterogeneity and coronary heart disease.

Fievet C, Fruchart JC. Fievet C, et al. Diabetes Metab Rev. 1991 Sep;7(3):155-62. doi: 10.1002/dmr.5610070304. Diabetes Metab Rev. 1991. PMID: 1817000 Review. No abstract available.

6

Relation of arteriographically defined coronary artery disease to serum lipoprotein particles mapped with monoclonal antibodies.

Fiévet C, Nuttens MC, Ducimetière P, Fruchart JC, Bertrand M, Salomez JL. Fiévet C, et al. Circulation. 1991 Jul;84(1):153-9. doi: 10.1161/01.cir.84.1.153. Circulation. 1991. PMID: 2060091

7

[Determination of blood profile of atherogenic lipids using immunologic techniques].

Fruchart JC, Bard JM, Clavey V, Fievet C. Fruchart JC, et al. Among authors: fievet c. Klin Wochenschr. 1990;68 Suppl 22:43-5. Klin Wochenschr. 1990. PMID: 2087078 German.

8

[Molecular analysis of atherogenic and protective lipoproteins].

Fruchart JC, Bard JM, Fievet C, Puchois P. Fruchart JC, et al. Among authors: fievet c. Arch Mal Coeur Vaiss. 1987 Sep;80 Spec No:13-6. Arch Mal Coeur Vaiss. 1987. PMID: 2445318 French. No abstract available.

9

Electroimmuno- and immunonephelometric assays of apolipoprotein A-I by using a mixture of monoclonal antibodies.

Pruvot I, Fievet C, Durieux C, Vu Dac N, Fruchart JC. Pruvot I, et al. Among authors: fievet c. Clin Chem. 1988 Oct;34(10):2048-52. Clin Chem. 1988. PMID: 3139327

10

Molecular analysis of atherogenic lipoprotein particles in adequately controlled type I diabetes mellitus.

Fievet C, Méjean L, Drouin P, Fruchart JC. Fievet C, et al. Adv Exp Med Biol. 1988;243:279-82. doi: 10.1007/978-1-4613-0733-4_35. Adv Exp Med Biol. 1988. PMID: 3223420 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters